Innospec IOSP Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $289.1M-3.6% | $292.5M+1.1% | $270.8M-10.9% | $266.6M+11.0% | $299.8M+11.0% | ||
| $354.2M+3.1% | $342.3M+0.2% | $349.5M+6.7% | $336.1M+11.9% | $343.5M+8.0% | ||
| $321.5M+1.9% | $329.3M+9.4% | $345.2M+8.1% | $336.8M+7.4% | $315.4M+3.6% | ||
| $999.1M+2.3% | $1B+5.0% | $988.8M+2.4% | $969.7M+10.6% | $977.1M+7.0% | ||
| $285.7M+3.1% | $286.1M+6.1% | $278.6M+0.1% | $295.8M+8.8% | $277.1M+3.1% | ||
| $399.1M+2.8% | $399M+4.3% | $2M-99.5% | $397.6M+2.4% | $388.4M-2.3% | ||
| $68.9M-5.4% | $67.7M+3.5% | $63.3M-0.5% | $78.3M+27.5% | $72.8M+26.2% | ||
| $1.82B+2.5% | $1.83B+5.6% | $1.8B+0.1% | $1.81B+6.2% | $1.77B+2.4% | ||
| $138.5M-18.3% | $174.7M+6.7% | $162.2M-4.0% | $149.4M+1.2% | $169.5M+1.9% | ||
| $334.8M-6.4% | $360.1M-3.0% | $356.1M-4.6% | $337.4M+1.4% | $357.6M-2.0% | ||
| $467.6M-8.1% | $499.5M-3.7% | $496.5M-9.7% | $504.6M0.0% | $508.9M-6.9% | ||
| $300K0.0% | $300K0.0% | $300K0.0% | $300K0.0% | $300K0.0% | ||
| $1.13B+6.8% | $1.1B+7.2% | $1.07B-3.7% | $1.06B-2.0% | $1.06B-1.1% | ||
| $1.35B+6.7% | $1.33B+9.5% | $1.3B+4.3% | $1.3B+8.6% | $1.26B+6.5% | ||
| $1.82B+2.5% | $1.83B+5.6% | $1.8B+0.1% | $1.81B+6.2% | $1.77B+2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Innospec cover its short-term obligations?
- Its current ratio is 2.98 — current assets exceed current liabilities.
- Where does Innospec's balance sheet data come from?
- Every line is extracted from Innospec's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.